Persistent Asset Partners LTD Vertex Pharmaceuticals Inc Put Options Transaction History
Persistent Asset Partners LTD
- $135 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding VRTX
# of Institutions
1,786Shares Held
236MCall Options Held
1.95MPut Options Held
1.14M-
Capital World Investors Los Angeles, CA28.7MShares$12.1 Billion1.94% of portfolio
-
Vanguard Group Inc Valley Forge, PA24MShares$10.1 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$8.99 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA16.1MShares$6.79 Billion1.5% of portfolio
-
State Street Corp Boston, MA11.8MShares$4.97 Billion0.2% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $108B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...